http://hdl.handle.net/1765/17554
http://dx.doi.org/10.1016/S0959-8049(09)70050-4
scopus: 70349107924
http://dx.doi.org/10.1016/S0959-8049(09)70050-4
scopus: 70349107924
Prostate cancer - chemoprevention
September 2009
Article
volume 45, issue SUPPL. 1 pp 355-359.
| Related Files |
|---|
|
Redirect to publisher's version
(publisher's version.url.txt, 47 bytes) |
Repository contains one additional file which is not publicly available
Keywords
- article
- human
- priority journal
- prostate cancer
- clinical trial
- drug dose comparison
- diabetes mellitus
- cancer growth
- cancer incidence
- cancer mortality
- lung cancer
- cancer risk
- colorectal cancer
- placebo
- prognosis
- secondary prevention
- prostate specific antigen
- disease duration
- high risk population
- alpha tocopherol
- dutasteride
- finasteride
- selenium
- vitamin supplementation
- primary prevention
- digital rectal examination
- chemoprophylaxis
- lycopene
- quercetin
- skin carcinoma
